There is considerable evidence that GLP1-RA confer cardiovascular and renal protective effects in patients with and without diabetes12
PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
FBCM is currently considered to be the most common cause of vitamin B12 deficiency, caused by impairment in the release of the vitamin from food, commonly because of conditions such as gastritis, achlorhydria, gastrectomy, use of antacids, or proton pump inhibitors (PPIs), gastric atrophy in the elderly, and Helicobacter pylori infection (63, 74)
That is 50 pounds in six months
The Bottom Line Retatrutide is the most powerful weight loss drug in development
in addition to established first-line treatments such as reninangiotensinaldosterone system inhibitors (RAASi
